LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 102 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 2.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,103 | +350.3% | 1,402,123 | +251.4% | 0.00% | – |
| Q4 2022 | $467 | -99.9% | 399,039 | -21.2% | 0.00% | – |
| Q3 2022 | $572,000 | -64.5% | 506,313 | -50.4% | 0.00% | -100.0% |
| Q2 2022 | $1,612,000 | +486.2% | 1,020,446 | +471.7% | 0.00% | – |
| Q1 2022 | $275,000 | -66.3% | 178,493 | -46.4% | 0.00% | – |
| Q4 2021 | $816,000 | +1565.3% | 333,220 | +1615.4% | 0.00% | – |
| Q3 2021 | $49,000 | -98.5% | 19,425 | -98.6% | 0.00% | -100.0% |
| Q1 2021 | $3,351,000 | +437.0% | 1,425,776 | +301.9% | 0.00% | – |
| Q4 2020 | $624,000 | +86.3% | 354,753 | -0.8% | 0.00% | – |
| Q3 2020 | $335,000 | +2691.7% | 357,528 | +2417.8% | 0.00% | – |
| Q2 2020 | $12,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,935,485 | $55,198,000 | 4.16% |
| Raffles Associates | 1,930,536 | $3,050,000 | 3.32% |
| Defender Capital, LLC. | 5,131,935 | $8,108,000 | 3.18% |
| Prescott General Partners LLC | 1,851,851 | $2,926,000 | 0.20% |
| DAFNA Capital Management LLC | 140,000 | $221,000 | 0.06% |
| Laurion Capital Management LP | 2,422,367 | $3,827,000 | 0.06% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $71,000 | 0.05% |
| Fort Sheridan Advisors LLC | 78,931 | $125,000 | 0.04% |
| Long Focus Capital Management, LLC | 215,000 | $340,000 | 0.04% |
| MORGAN JESS S & CO INC | 20,000 | $32,000 | 0.03% |